Allergy

Biosimilars

Cardiology

Dermatology

Endocrinology

Family Medicine

Gastroenterology

Geriatrics

Hospital Medicine

Infectious Disease

Internal Medicine

Nephrology

Neurology

Obesity Management

Ophthalmology

Pain

Pediatrics

Psychiatry

Pulmonology

Rare Disease Report®

Rheumatology

Sleep

Surgery

Women's Health

News

Media

Medical World News

Podcasts

Shows

State Of Sciences - Presentations

Videos

Webinars

Multimedia Series

Insights

Medcast Podcasts

Medcast Videos

Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

Partners

CME/CE

Resources

Interactive Tools

Live Events

Press Release

Publications

Subscribe

Articles

According to the results, 42.8% of participants failed to agree that relevant legislature is in place for the sickle cell disease population, as it doesn't facilitate optimal access to high-quality healthcare.

Analysis of Sickle Cell Disease Policies and Practices in Nigeria

Connor Iapoce is an associate editor for 

 and joined the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to concerts, and playing with his cat Squish. You can reach him at 

An analysis of Denmark's FORSYN study suggests new advances in the treatment of chorioretinal vascular diseases have significantly reduced vision loss. 

Anti-VEGF Therapy Linked to Significant Decrease in Vision Loss Prevalence 

Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.

Announced on February 7, the US FDA notification is aimed at alerting consumers around presence of sildenafil and tadalafil in PrimeZen Black 6000, which the agency purports could pose a significant risk for people using nitrates for other chronic conditions, such as diabetes and cardiovascular disease.

FDA Issues Notice Surrounding Hidden Ingredients in Sexual Enhancement Product

Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.

The systematic review compared mHealth interventions with conventional treatment or nonintervention to determine the pain management effects of mobile-based self-management strategies. 

Mobile Health Systems Improve Pain Intensity, Quality of Life in Patients with Chronic Pain

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

About Us

Advertise

Editorial

Contact Us

Do Not Sell My Information

Privacy

Terms & Conditions

HCPLive - Clinical news for connected physicians

Facebook

Twitter

LinkedIn

Spotlight

Biosimilars Spotlight

COVID-19

Qazi Corner

This Year In Medicine 2022

Clinical

ADHD

Arterial Disease

Diabetes

Geriatric Medicine

Video Series

News Network

Post Conference Perspectives

Register today to join our colleagues at OncLive

 for an exclusive event on December 8, 2022. You and your peers have the 

option of joining us live, in-person at 7 locations across the US

 or virtaully from the comfort of your home or office. Discover new insights on 

 (HCC) designed to improved patient outcomes.

Discuss current frontline treatment options and unmet needs for patients with advanced HCC

Share expert insight on recent updates to the HCC treatment armamentarium

Analyze new data and therapies on the horizon for unresectable HCC

7:00pm ET | 6:00pm CT | 5:00pm MT | 4:00pm PT

9:00pm ET | 8:00pm CT | 7:00pm MT | 6:00pm PT

Gaining Ground: New Options for Advanced HCC

HCPLive® State of the Science events are short meetings designed to educate health care providers on the clinical benefits associated with the new science driving new thinking in their field. Our renowned faculty focus on the most relevant topics so HCP attendees improve their knowledge of treatment approaches and leave our events with the confidence and intent to apply these lessons learned to improve patient care.

Registration for this virtual event is complimentary and HCPs are encouraged to share their feedback in our post-event survey.



State of Science Summit in Psychiatry: Addressing Challenges in Depression Treatment

The Role of JAK Inhibition in Vitiligo Treatment

State of the Science Summit in Dermatology: Vitiligo

HCPLive® State of the Science events are short meetings designed to educate health care providers on the clinical benefits associated with the new science driving new thinking in their field. Our renowned faculty focus on the most relevant topics so HCP attendees improve their knowledge of treatment approaches and leave our events with the confidence and intent to apply these lessons learned to improve patient care.

Registration for this virtual event is complimentary and HCPs are encouraged to share their feedback in our post-event survey.

Psychedelic Medicine and the Future of Psychiatry

Psychedelic-Assisted Psychotherapy for Depression

State of the Science in Psychiatry: Addressing Challenges in Depression Treatment

Join Linda Stein Gold, MD and Larry Eichenfield, MD for an informative presentation about recent developments in atopic dermatitis (AD). They will review the evolving understanding of AD, diagnosis, management, the patient journey, and new novel treatment option in a presentation hosted by Incyte Dermatology.

The Burden of Atopic Dermatitis and a Novel Topical Pathway

, chief medical officer with the American Lung Association and clinical assistant professor of medicine at Sidney Kimmel Medical College, for a live webinar event on 

along with an esteemed panel of experts to hear how the COVID-19 pandemic affected lung cancer screening and treatment.

Opportunities borne from effective screening

Effective screening-to-treatment plans: what does it look like for a patient?

Part 2 - Lung Cancer Screening & Treatment: What Comes Next?

Topics of discussion include:
•Recent research and trends into lung cancer screening
•The clinical impact of lacking screening
•The effect of COVID-19 on lung cancer screening
•The US Preventive Services Task Force 2021 Lung Cancer Screening Guidelines

Lung Cancer Screening & Treatment After COVID-19

State of Sciences-Presentations

1rem

Experts share insights on evolving knowledge and treatment approaches regarding vitiligo, in highlights from a recent State of the Science SummitTM, presented by HCP Live®.